Loading…

Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study

The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiothoracic surgery 2024-06, Vol.19 (1), p.340-10, Article 340
Main Authors: Micovic, Slobodan, Nobre, Angelo, Choi, Jae Woong, Solinas, Marco, Shehada, Sharaf-Eldin, Torella, Michele, Baeza, Cristian, Parrino, Eugene, Pollari, Francesco, Troise, Giovanni, Kappert, Utz, Mellert, Friedrich, Je, Hyung Gon, Argano, Vincenzo, Lam, Ka Yan, Rinaldi, Mauro, Gutermann, Herbert, Meuris, Bart
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033
container_end_page 10
container_issue 1
container_start_page 340
container_title Journal of cardiothoracic surgery
container_volume 19
creator Micovic, Slobodan
Nobre, Angelo
Choi, Jae Woong
Solinas, Marco
Shehada, Sharaf-Eldin
Torella, Michele
Baeza, Cristian
Parrino, Eugene
Pollari, Francesco
Troise, Giovanni
Kappert, Utz
Mellert, Friedrich
Je, Hyung Gon
Argano, Vincenzo
Lam, Ka Yan
Rinaldi, Mauro
Gutermann, Herbert
Meuris, Bart
description The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days. A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p 
doi_str_mv 10.1186/s13019-024-02861-1
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A798501173</galeid><doaj_id>oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b</doaj_id><sourcerecordid>A798501173</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</originalsourceid><addsrcrecordid>eNptkkFv1DAUhCMEoqXwBzggS1y4pNixE8dc0KoqUGmBCtqz5TjPu14l8WI7i_bOD8fZlNJFKIoS-c180bxMlr0k-JyQunobCMVE5Lhg6a4rkpNH2SnhTOQ1Fvjxg_eT7FkIG4xZSXH5NDuhtcAFZ8Vp9utS-W6P3Bi16yEgZ5ByPlqNdqrbAfKw7ZSGHoaIftq4RtfgNaQZul7efkdhjKOHDkKY9e-SIYxdPIDiGtDWu7AFHW1i9WlgdSL5hP-8-HLzbYFCHNv98-yJUV2AF3fPs-z2w-XNxad8-fXj1cVimWvGypgzULQhmLe6YYbjFhctCIZbQuumEgoKUpqqopjTltVatJgbKDGh3GBqBKb0LLuaua1TG7n1tld-L52y8nDg_EqqKXsHUnPQjBrTFLxmoNPCyoIqEHgCGd4k1vuZtR2bHtpDLNUdQY8ng13LldtJQoggRcUT4c0dwbsfI4Qoexs0dJ0awI1BpiC4ppxTlqSv_5Fu3OiHtKtJJYqSCEH_qlYqJbCDcenDeoLKBRd1WgXhk-r8P6p0tdBb7QYwNp0fGYrZoNO_DB7MfUiC5VREORdRpiLKQxElSaZXD9dzb_nTPPobUcjZSg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3079251993</pqid></control><display><type>article</type><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><source>PubMed Central (Open Access)</source><source>ProQuest - Publicly Available Content Database</source><creator>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart</creator><creatorcontrib>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart ; MANTRA Investigators ; the MANTRA Investigators</creatorcontrib><description>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days. A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p &lt; 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p &lt; 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported. Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS. The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</description><identifier>ISSN: 1749-8090</identifier><identifier>EISSN: 1749-8090</identifier><identifier>DOI: 10.1186/s13019-024-02861-1</identifier><identifier>PMID: 38902742</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Aged ; Aged, 80 and over ; Aorta ; Aortic valve ; Aortic Valve - surgery ; Aortic valve replacement ; Aortic Valve Stenosis - surgery ; Catheters ; Disease ; Female ; Heart ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation - methods ; Heart valves ; Hemodynamics ; Hemodynamics - physiology ; Humans ; Male ; Middle Aged ; Mineralization ; Mortality ; Ostomy ; Patients ; Perceval plus ; Prospective Studies ; Prostheses ; Prosthesis Design ; Quality of Life ; Questionnaires ; Real-life data ; Recovery (Medical) ; Surgeons ; Surgery ; Sutureless Surgical Procedures - methods ; Sutureless valve ; Treatment Outcome</subject><ispartof>Journal of cardiothoracic surgery, 2024-06, Vol.19 (1), p.340-10, Article 340</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191267/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3079251993?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38902742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Micovic, Slobodan</creatorcontrib><creatorcontrib>Nobre, Angelo</creatorcontrib><creatorcontrib>Choi, Jae Woong</creatorcontrib><creatorcontrib>Solinas, Marco</creatorcontrib><creatorcontrib>Shehada, Sharaf-Eldin</creatorcontrib><creatorcontrib>Torella, Michele</creatorcontrib><creatorcontrib>Baeza, Cristian</creatorcontrib><creatorcontrib>Parrino, Eugene</creatorcontrib><creatorcontrib>Pollari, Francesco</creatorcontrib><creatorcontrib>Troise, Giovanni</creatorcontrib><creatorcontrib>Kappert, Utz</creatorcontrib><creatorcontrib>Mellert, Friedrich</creatorcontrib><creatorcontrib>Je, Hyung Gon</creatorcontrib><creatorcontrib>Argano, Vincenzo</creatorcontrib><creatorcontrib>Lam, Ka Yan</creatorcontrib><creatorcontrib>Rinaldi, Mauro</creatorcontrib><creatorcontrib>Gutermann, Herbert</creatorcontrib><creatorcontrib>Meuris, Bart</creatorcontrib><creatorcontrib>MANTRA Investigators</creatorcontrib><creatorcontrib>the MANTRA Investigators</creatorcontrib><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><title>Journal of cardiothoracic surgery</title><addtitle>J Cardiothorac Surg</addtitle><description>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days. A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p &lt; 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p &lt; 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported. Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS. The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aorta</subject><subject>Aortic valve</subject><subject>Aortic Valve - surgery</subject><subject>Aortic valve replacement</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Catheters</subject><subject>Disease</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation - methods</subject><subject>Heart valves</subject><subject>Hemodynamics</subject><subject>Hemodynamics - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mineralization</subject><subject>Mortality</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Perceval plus</subject><subject>Prospective Studies</subject><subject>Prostheses</subject><subject>Prosthesis Design</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Real-life data</subject><subject>Recovery (Medical)</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Sutureless Surgical Procedures - methods</subject><subject>Sutureless valve</subject><subject>Treatment Outcome</subject><issn>1749-8090</issn><issn>1749-8090</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkkFv1DAUhCMEoqXwBzggS1y4pNixE8dc0KoqUGmBCtqz5TjPu14l8WI7i_bOD8fZlNJFKIoS-c180bxMlr0k-JyQunobCMVE5Lhg6a4rkpNH2SnhTOQ1Fvjxg_eT7FkIG4xZSXH5NDuhtcAFZ8Vp9utS-W6P3Bi16yEgZ5ByPlqNdqrbAfKw7ZSGHoaIftq4RtfgNaQZul7efkdhjKOHDkKY9e-SIYxdPIDiGtDWu7AFHW1i9WlgdSL5hP-8-HLzbYFCHNv98-yJUV2AF3fPs-z2w-XNxad8-fXj1cVimWvGypgzULQhmLe6YYbjFhctCIZbQuumEgoKUpqqopjTltVatJgbKDGh3GBqBKb0LLuaua1TG7n1tld-L52y8nDg_EqqKXsHUnPQjBrTFLxmoNPCyoIqEHgCGd4k1vuZtR2bHtpDLNUdQY8ng13LldtJQoggRcUT4c0dwbsfI4Qoexs0dJ0awI1BpiC4ppxTlqSv_5Fu3OiHtKtJJYqSCEH_qlYqJbCDcenDeoLKBRd1WgXhk-r8P6p0tdBb7QYwNp0fGYrZoNO_DB7MfUiC5VREORdRpiLKQxElSaZXD9dzb_nTPPobUcjZSg</recordid><startdate>20240621</startdate><enddate>20240621</enddate><creator>Micovic, Slobodan</creator><creator>Nobre, Angelo</creator><creator>Choi, Jae Woong</creator><creator>Solinas, Marco</creator><creator>Shehada, Sharaf-Eldin</creator><creator>Torella, Michele</creator><creator>Baeza, Cristian</creator><creator>Parrino, Eugene</creator><creator>Pollari, Francesco</creator><creator>Troise, Giovanni</creator><creator>Kappert, Utz</creator><creator>Mellert, Friedrich</creator><creator>Je, Hyung Gon</creator><creator>Argano, Vincenzo</creator><creator>Lam, Ka Yan</creator><creator>Rinaldi, Mauro</creator><creator>Gutermann, Herbert</creator><creator>Meuris, Bart</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240621</creationdate><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><author>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aorta</topic><topic>Aortic valve</topic><topic>Aortic Valve - surgery</topic><topic>Aortic valve replacement</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Catheters</topic><topic>Disease</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation - methods</topic><topic>Heart valves</topic><topic>Hemodynamics</topic><topic>Hemodynamics - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mineralization</topic><topic>Mortality</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Perceval plus</topic><topic>Prospective Studies</topic><topic>Prostheses</topic><topic>Prosthesis Design</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Real-life data</topic><topic>Recovery (Medical)</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Sutureless Surgical Procedures - methods</topic><topic>Sutureless valve</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Micovic, Slobodan</creatorcontrib><creatorcontrib>Nobre, Angelo</creatorcontrib><creatorcontrib>Choi, Jae Woong</creatorcontrib><creatorcontrib>Solinas, Marco</creatorcontrib><creatorcontrib>Shehada, Sharaf-Eldin</creatorcontrib><creatorcontrib>Torella, Michele</creatorcontrib><creatorcontrib>Baeza, Cristian</creatorcontrib><creatorcontrib>Parrino, Eugene</creatorcontrib><creatorcontrib>Pollari, Francesco</creatorcontrib><creatorcontrib>Troise, Giovanni</creatorcontrib><creatorcontrib>Kappert, Utz</creatorcontrib><creatorcontrib>Mellert, Friedrich</creatorcontrib><creatorcontrib>Je, Hyung Gon</creatorcontrib><creatorcontrib>Argano, Vincenzo</creatorcontrib><creatorcontrib>Lam, Ka Yan</creatorcontrib><creatorcontrib>Rinaldi, Mauro</creatorcontrib><creatorcontrib>Gutermann, Herbert</creatorcontrib><creatorcontrib>Meuris, Bart</creatorcontrib><creatorcontrib>MANTRA Investigators</creatorcontrib><creatorcontrib>the MANTRA Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of cardiothoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Micovic, Slobodan</au><au>Nobre, Angelo</au><au>Choi, Jae Woong</au><au>Solinas, Marco</au><au>Shehada, Sharaf-Eldin</au><au>Torella, Michele</au><au>Baeza, Cristian</au><au>Parrino, Eugene</au><au>Pollari, Francesco</au><au>Troise, Giovanni</au><au>Kappert, Utz</au><au>Mellert, Friedrich</au><au>Je, Hyung Gon</au><au>Argano, Vincenzo</au><au>Lam, Ka Yan</au><au>Rinaldi, Mauro</au><au>Gutermann, Herbert</au><au>Meuris, Bart</au><aucorp>MANTRA Investigators</aucorp><aucorp>the MANTRA Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</atitle><jtitle>Journal of cardiothoracic surgery</jtitle><addtitle>J Cardiothorac Surg</addtitle><date>2024-06-21</date><risdate>2024</risdate><volume>19</volume><issue>1</issue><spage>340</spage><epage>10</epage><pages>340-10</pages><artnum>340</artnum><issn>1749-8090</issn><eissn>1749-8090</eissn><abstract>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days. A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p &lt; 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p &lt; 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported. Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS. The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38902742</pmid><doi>10.1186/s13019-024-02861-1</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1749-8090
ispartof Journal of cardiothoracic surgery, 2024-06, Vol.19 (1), p.340-10, Article 340
issn 1749-8090
1749-8090
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b
source PubMed Central (Open Access); ProQuest - Publicly Available Content Database
subjects Aged
Aged, 80 and over
Aorta
Aortic valve
Aortic Valve - surgery
Aortic valve replacement
Aortic Valve Stenosis - surgery
Catheters
Disease
Female
Heart
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation - methods
Heart valves
Hemodynamics
Hemodynamics - physiology
Humans
Male
Middle Aged
Mineralization
Mortality
Ostomy
Patients
Perceval plus
Prospective Studies
Prostheses
Prosthesis Design
Quality of Life
Questionnaires
Real-life data
Recovery (Medical)
Surgeons
Surgery
Sutureless Surgical Procedures - methods
Sutureless valve
Treatment Outcome
title Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20outcomes%20of%20aortic%20valve%20replacement%20with%20Perceval%20PLUS%20sutureless%20valve:%20results%20of%20the%20prospective%20multicentric%20MANTRA%20study&rft.jtitle=Journal%20of%20cardiothoracic%20surgery&rft.au=Micovic,%20Slobodan&rft.aucorp=MANTRA%20Investigators&rft.date=2024-06-21&rft.volume=19&rft.issue=1&rft.spage=340&rft.epage=10&rft.pages=340-10&rft.artnum=340&rft.issn=1749-8090&rft.eissn=1749-8090&rft_id=info:doi/10.1186/s13019-024-02861-1&rft_dat=%3Cgale_doaj_%3EA798501173%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3079251993&rft_id=info:pmid/38902742&rft_galeid=A798501173&rfr_iscdi=true